Original Article
European Journal of Clinical Nutrition (2007) 61, 548–553. doi:10.1038/sj.ejcn.1602554; published online 22 November 2006
Prevalence of the metabolic syndrome among Turkish adults
Guarantor: A Abaci.
Contributors: OK, AO, AA, CE, ZO, AT and SC participated in the design and conduct of the study. All the authors contributed to the writing and revision of the paper for which AA is guarantor. The order of the contributors was agreed among the investigators, and the first listed contributor made the greatest contribution to the paper, and then in decreasing order.
O Kozan1, A Oguz2, A Abaci3, C Erol4, Z Ongen5, A Temizhan6 and S Celik7
- 1Department of Cardiology, School of Medicine, Dokuz Eylül University,
zmir, Turkey - 2SSK Göztepe Hospital, Istanbul, Turkey
- 3Department of Cardiology, School of Medicine, Gazi University, Ankara, Turkey
- 4Department of Cardiology, School of Medicine, Ankara University, Ankara, Turkey
- 5Department of Cardiology, Cerrahpa
a School of Medicine, stanbul University, Istanbul, Turkey - 6Department of Cardiology, Türkiye Yüksek htisas Hastanesi, Ankara, Turkey
- 7Department of Cardiology, School of Medicine, Karadeniz Teknik University, Trabzon, Turkey
Correspondence: Dr A Abaci, Department of Cardiology, Gazi Universitesi Tip Fakultesi, Kardiyoloji Anabilim Dali, Beevler/Ankara 06500, Turkey. E-mail: abaci@gazi.edu.tr
Received 14 November 2005; Revised 27 July 2006; Accepted 27 September 2006; Published online 22 November 2006.
Abstract
Objective:
To determine prevalence of the metabolic syndrome (MS) in a sample representing Turkish population using United States Adult Treatment Panel-3 guidelines.
Design:
The study included random samples from both urban and rural populations in the seven geographical regions of Turkey. The population for this analysis were 2108 men (1372 in urban and 736 in rural areas) and 2151 women (1423 in urban and 728 in rural areas) with a mean age of 40.9
14.9 years (range 20–90).
Results:
The prevalence of the MS diagnosed using the Adult Treatment Panel III criteria was 33.9% (1442 of 4259) and differed significantly in men (28%) and women (39.6%). The prevalence of syndrome increased with age in men, from 10.7% in subjects aged 20–29 years to 49% in those aged over 70 years. The prevalence increased with age in women, from 9.6% in subjects aged 20–29 years to 74.6% in those aged 60–69 years, and decreased to 68.6% in those over 70 years of age. The prevalence of the syndrome was similar in urban (33.8%) and rural (33.9%) population. We found 26.8, 26.4, 19.3, 10.9 and 3.6% of the population had at least 1, 2, 3, 4 or 5 components, respectively. We found 57.2, 32.3 and 10.6% of the subjects with MS had 3, 4 and 5 components, respectively.
Conclusions:
The prevalence of the MS in the adult Turkish population is very high, especially in women. Our findings have important implications for public health in Turkey.
Keywords:
metabolic, syndrome, prevalence
MORE ARTICLES LIKE THIS
These links to content published by NPG are automatically generated
RESEARCH
Effects of leptin on energy metabolism in β-less mice
International Journal of Obesity Original Article
Synthesis and metabolism of cysteinyl leukotrienes by the isolated pig kidney
Kidney International Original Article
Prevalence of the metabolic syndrome among Turkish adults
European Journal of Clinical Nutrition Original Article
Prevalence of Obesity and Associated Risk Factors in a Turkish Population (Trabzon City, Turkey) **
Obesity Research Original Article
